Committee on Infectious Diseases. Recommendations for Prevention and Control of Influenza in Children, 2024-2025: Technical Report. Pediatrics. 2024 Aug 26:e2024068508
This technical report accompanies the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccine and antiviral medications in the prevention and treatment of influenza in children during the 2024 to 2025 season. The rationale for the American Academy of Pediatrics recommendation for annual influenza vaccination of all children without medical contraindications starting at 6 months of age is provided. Influenza vaccination is an important strategy for protecting children and the broader community against influenza. This technical report summarizes recent influenza seasons, morbidity and mortality in children, vaccine effectiveness, and vaccination coverage and provides detailed guidance on vaccine storage, administration, and implementation. The report also provides a brief background on inactivated (nonlive) and live attenuated influenza vaccines, available vaccines for the 2024-2025 influenza season, vaccination during pregnancy and breastfeeding, diagnostic testing for influenza, and antiviral medications for treatment and chemoprophylaxis. Strategies to promote vaccine uptake are emphasized.
See Also:
Latest articles in those days:
- Cluster of Influenza A(H5) Cases Associated with Poultry Exposure at Two Facilities - Colorado, July 2024 2 days ago
- Influenza virus antibodies inhibit antigen-specific de novo B cell responses in mice 3 days ago
- Host response to influenza infections in human blood: association of influenza severity with host genetics and transcriptomic response 3 days ago
- Highly Pathogenic Avian Influenza Virus H5N1 clade 2.3.4.4b in Wild Rats in Egypt during 2023 3 days ago
- Whole-genome analysis of circulating influenza A virus (H3N2) strains in Shanghai, China from 2005 to 2023 4 days ago
[Go Top] [Close Window]